Total Reports
18
Below-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Crossbred rabbit (Rabbit) in the FDA Center for Veterinary Medicine openFDA extract. Browse rabbit breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Crossbred rabbit, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Crossbred rabbit ranks #375 of 510 by total reports (18). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Crossbred rabbit has 18 reports now versus 16 in that prior snapshot: 2 more (12.5%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Crossbred rabbit changesTotal Reports
18
Below-median volume
Deaths Reported
4
of 18 reports
Death-coded share of reports
22.2%
22.2% death-coded
Avg Age at Report
0.9 yr
2.0 kg avg weight
22.2% of 18 crossbred rabbit reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2019 | 1 | |
| 2020 | 11 | |
| 2021 | 1 | |
| 2022 | 3 | |
| 2026 | 2 | |
Signature read: 18 reports place Crossbred rabbit in the lower third of breed filing volume (#377 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Crossbred rabbit sits at #377 of 510 by report volume among all breeds and #4 of 7 among rabbit breeds, with 18 reports and 4 (22.2%) death-coded. Mean age at report: 0.9 years, average weight 2.0 kg (4.4 lbs).
Top reported signs: Skin oedema (6), Anorexia (5), Lethargy (see also Central nervous system depression in Neurological) (3). Most-referenced drug: Meloxicam (31 reports), followed by Midazolam (11) and Ketamine Hydrochloride (8).
Outcome coding on 18 status-recorded reports is dominated by Recovered/Normal (61.1%). Annual submissions ranged 1-2,026 across 5 years on file.
Sparse-volume peer sets for Crossbred rabbit drawn from openFDA outside the Rabbit family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (2.0 kg here).
What to do with this rabbit
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →